Real-world health policy, population health, and health insurance data analyses
Teus Health provides clients analytic and public policy support within the intersecting domains of population health and health insurance, with a particular emphasis on the analysis of healthcare costs. We find health policy and management insights within real-world, messy primary and secondary data, including health insurance claims-level data. We present the findings in clear, easy to understand graphics, presentations, and reports. We can set up ongoing reporting processes and train your team. Our work spans all phases of the analytics life cycle, from acquiring and exploring the data to analytic plan development to final reporting.
Latest Publications
-
What You Should Know About Medicare Advantage Home Visits
Newsweek Experts
“According to the government, "The healthcare providers... who conducted these home visits did not perform or order the testing or imaging that would have been necessary to reliably diagnose the serious, complex conditions reported and were prohibited by CIGNA from providing any treatment during the home visit for the medical conditions purportedly found…
-
QALYs: The Math Doesn’t Work
Journal of Health Economics and Outcomes Research
“If we ask relatives, friends, and strangers how they measure their health and quality of life, their responses are likely to be as complex and unique as snowflakes. Yet, QOL measurement developers reduce quality-of-life measurements to a handful of simplistic questions. Furthermore, their question sets are inconsistent with each other and with common perceptions of health…”
-
Born On Third Base: Medicare Advantage Thrives On Subsidies, Not Better Care
Health Affairs
“Over the past seven years, Medicare Advantage’s (MA’s) enrollment has almost doubled, adding 10 percent to its market share , now at 49 percent. Rebates, the additional dollars paid by CMS to MA plans that bid beneath their “benchmark”…”
-
Drug Cost-Effectiveness Assessments Require Standards for Rigor and Inclusion
Journal of Health Economics and Outcomes Research
“The lack of standards for cost-effectiveness assessments and use of nongeneralizable data can distort the benefits of new treatments and undermine the progress the scientific community…”
-
Medicare Telehealth Analysis
Politico
“Telehealth did not increase the number of visits, rather that it served as a substitute for certain in-person encounters. Further, it indicated that telehealth was mostly utilized for patients whose medical needs required multiple primary care visits during each year, suggesting that these telehealth encounters…”
-
The Dawn of Self-Insured Transparency
Self-Published
“Self-insured employers are therefore paying too much and not fulfilling their plan responsibilities if they are not watching for and addressing fraud, waste, and abuse, and overpricing – a task that recently became easier as a result of provisions of the Consolidated Appropriations Act (CAA) of 2021…”